A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 105, Issue 2, 2008, Pages 187-193

  Radfar, Lida ^a   Wild, Robert C ^b   Suresh, Lakshmanan ^c  

^a School of Dental Medicine at SUNY   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c IMMCO Diagnostics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CLOBETASOL; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LICHEN PLANUS; MALE; MIDDLE AGED; OINTMENT; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CLOBETASOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 38949108691     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.07.029     Document Type: Article

References (50)

1. Sugerman P.B., Savage N.W., Walsh L.J., Zhao Z.Z., Zhou X.J., Khan A., et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13 (2002) 350-365
2. Wilson E. On lichen planus. J Cutan Med Dis Skin 3 (1869) 117-132
3. Vann Dis M.L., and Parks E.T. Prevalence of oral lichen planus in patients with diabetic mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 (1995) 696-700
4. Brown R.S., Bottomley W.K., Puente E., and Lavigne G.I. A retrospective evaluation of 193 patients with oral lichen planus. J Oral Pathol Med 22 (1993) 69-72
5. Eisen D. The therapy of oral lichen planus. Crit Rev Oral Biol Med 4 (1993) 141-158
6. Lozada-Nur F., and Miranda C. Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin Cutan Med Surg 16 (1997) 273-277
7. Ingafou M., Leao J.C., Porter S.R., and Scully C. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis 12 (2006) 463-468
8. Setterfield J.F., Black M.M., and Challacombe S.J. The management of oral lichen planus. Clin Exp Dermatol 25 (2000) 176-182
9. Voute A.B., Schulten E.A., Langendijk P.N., Kostense P.J., and van der Waal I. Flucinonide in an adhesive base for the treatment of oral lichen planus: a double blind placebo controlled clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 75 (1993) 181-185
10. Boisnic S., Branchet M.C., Pascal F., et al. Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa: a clinical evaluation. Ann Dermatol 121 (1994) 459-463
11. Seig P., Von Domarus H., Von Zitzewitz V., Iven H., and Färber L. Topical cyclosporine in oral lichen planus: a controlled randomized prospective trial. Br J Dermatol 132 (1995) 790-794
12. Lundquist G., Forsgren H., Gajecki M., and Emtestam L. Photochemotherapy of oral lichen planus: a controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 (1995) 554-558
13. Aghahosseini F., Arbabi-Kalati F., Fashtami L.A., Fateh M., and Djavid G.E. Treatment of oral lichen planus with photodynamic therapy mediated methylene blue: a case report. Med Oral Patol Oral Cir Bucal 11 (2006) E126-E129
14. Sehgal V.N., Abrraham G.J., and Malik G.B. Griseofulvin therapy in lichen planus: a double-blind controlled trial. Br J Dermatol 87 (1972) 383-385
15. Eisen D. Hydroxychloroquine sulfate (plaquenil) improves oral lichen planus: an open trial. J Am Acad Dermatol 28 (1993) 609-612
16. Kumar B., Kaur I., and Bhattacharya M. Dapsone in lichen planus. [letter]. Acta Derm Venereol 74 (1994) 334
17. Nousari H.C., Goyal S., and Anhalt G.J. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol 135 (1999) 1420-1421
18. 2 laser therapy of oral mucosal lesions. J Clin Laser Med Surg 16 (1998) 299-304
19. Dereure O., Basset-Seguin N., and Guilhou J.J. Erosive lichen planus: dramatic response to thalidomide. Arch Dermatol 132 (1996) 1392-1393
20. Odak E., Yosipovitch G., David M., Ingber A., Chorev L., Lider O., et al. Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. J Am Acad Dermatol 38 (1998) 564-568
21. Epstein J.B., Wan L.S., Gorsky M., and Zhang L. Oral lichen planus: progress in understanding its malignant potiential and implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 32-37
22. Scully C., Eisen D., and Carrozzo M. The management of oral lichen planus. Am J Clin Dermatol 1 (2000) 287-306
23. Chan E.S., Thornhill M., and Zakrzewska J. Interventions for treating oral lichen planus. Cochrane Database Syst Rev 2 (2000) CD001168
24. Cribier B., Frances C., and Chosidow O. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol 134 (1998) 1521-1530
25. Lo Muzio L., della Valle A., Mignogna M.D., Pannone G., Bucci P., Bucci E., et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med 30 (2001) 611-617
26. Sardella A., Demarosi F., Oltolina A., Rimondini L., and Carrassi A. Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus. Oral Dis 4 (1998) 255-259
27. Carbone M., Goss E., Carrozzo M., Castellano S., Conrotto D., Broccoletti R., et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 32 (2003) 323-329
28. Rodstrom P., Hakeberg M., Jontel M., and Nordin P. Erosive oral lichen planus treated with clobetasol propionate and triamcinolone acetonide in Orabase: a double-blind clinical trial. J Dermatol Treat 5 (1994) 7-10
29. Lozada-Nur F., Miranda C., and Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate ointment in Orabase and 0.05% fluocinonide ointment in Orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 77 (1994) 598-604
30. Suresh L., Martinez Calixto L.E., and Radfar L. Successful treatment of mucous membrane pemphigoid with tacrolimus. Spec Care Dentist 26 (2006) 66-70
31. Kelly P.A., Burckart G.J., and Venkataramanan R. Tacrolimus: a new immunosuppressive agent 52 (1995) 1521-1535
32. Greaf I.A., Mermelstein P.G., Stankunas K., Neilson J.R., Deisseroth K., Tsien R.W., et al. L-Type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401 (1994) 703-708
33. Vente C., Reigh K., Rupprecht R., and Neumann C. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 140 (1999) 338-342
34. Rozycki T., Rogers R., Pittelkow M., McEvoy M., el-Azhary R., Bruce A., et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 46 (2002) 27-34
35. Kaliakatsou F., Hodgson T.A., Lewsey J.D., Hegarty A.M., Murphy A.D., and Porter S.R. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 46 (2002) 35-41
36. Lener E., Brieva J., Schachter M., West L., West D., el-Ashary R., et al. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 137 (2001) 419-422
37. Morrison L., Kratochvil III F.J., and Gorman A. An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 47 (2002) 617-620
38. Christians U., Braun F., Schmidt M., Kosian N., Schiebel H.M., Ernst L., et al. Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipients. Clin Chem 38 (1992) 2025-2032
39. Vincent S.H., Karanam B.V., Painter S.K., and Chiu S.H. In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P-450-3A as the major enzymes responsible for its metabolism. Arch Biochem Biophys 294 (1992) 454-460
40. Nghiem P., Pearson G., and Langley R. Tacrolimus and picrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 46 (2002) 228-241
41. Laeijendecker R., Tank B., Dekker S.K., and Neumann H.A. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol 86 (2006) 227-229
42. Lozada-Nur F.I., and Sroussi H.Y. Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 744-749
43. Fischer G., and Bradford J. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report. J Reprod Med 52 (2007) 329-331
44. Langeland T., and Engh V. Topical use of tacrolimus and squamous cell carcinoma on the penis. Br J Dermatol 152 (2005) 183-185
45. Bunker C.B., Neill S., and Staughton R.C. Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. Arch Dermatol 140 (2004) 1169
46. Becker J.C., Houben R., Vetter C.S., and Bröcker E.B. The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. BMC Cancer 6 (2006) 7
47. Niwa Y., Terashima T., and Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 149 (2003) 960-967
48. US Food and Drug Administration. FDA Public Health Advisory: Elidel (pimecrolimus) cream and Protopic (tacrolimus) ointment. http://www.fda.gov/cder/drug/advisory/elidel_protopic.htm (accessed March 10, 2005)
49. Berger T.G., Duvic M., Van Voorhees A.S., VanBeek M.J., Frieden I.J., and American Academy of Dermatology Association Task Force. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 54 (2006) 818-823
50. Ring J., Barker J., Behrendt H., Braathen L., Darsow U., Dubertret L., et al. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol 19 (2005) 663-671